U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193875) titled 'Efavirenz (EFV) Intensification' on Sept. 16.
Brief Summary: The goal of this clinical trial is to see if Efavirenz (EFV) intensification to a baseline combination antiretroviral regimen (cART) can help reduce the size of the latent reservoir in people living with HIV (PLWH). The main questions this study aims to address are:
1. is the addition of EFV to a cART regimen safe and well tolerated?
2. Is there a reduction in the blood and tissue HIV reservoir after intensification?
Researchers will compare each participants reservoir size prior to and post EFV intensification.
Study Start Date: Feb. 09, 2023
Study Type: INTERVENTIO...